Gain insight into research trends and influential papers with Research Intelligence.
doi.org/10.1097/01.ju.0000611504.41578.ee

Re: Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer

Samir S. Taneja
4
The Journal of Urology
Volume: 203, Issue: 1, Pages: 32 - 33
Published: Jan 1, 2020
Abstract
No AccessJournal of UrologyUrological Survey1 Jan 2020Re: Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer Samir S. TanejaMD Samir S. TanejaSamir S. Taneja More articles by this author View All Author Informationhttps://doi.org/10.1097/01.JU.0000611504.41578.eeAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Re: Enzalutamide with Standard...
Paper Fields
Paper Details
Title
Re: Enzalutamide with Standard First-Line Therapy in Metastatic Prostate Cancer
DOI
doi.org/10.1097/01.ju.0000611504.41578.ee
Published Date
Jan 1, 2020
Journal
The Journal of Urology
Volume
203
Issue
1
Pages
32 - 33
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.